# Abvc Biopharma, Inc.: Form 8-K, filed Jul 23, 2024

- Company: [Abvc Biopharma, Inc.](/companies/abvc.md) (CIK 1173313)
- Form: 8-K
- Filed: 2024-07-23
- Accepted by EDGAR: Jul 23, 2024, 17:00 ET
- Period: 2024-07-23
- Accession: 0001213900-24-063627
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1173313/000121390024063627/ea020990501-8k_abvcbio.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1173313/000121390024063627/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1173313/000121390024063627/ea020990501-8k_abvcbio.htm

Filed Jul 23, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-063627. Last ingested by Listed: Nov 11, 2026, 02:32 ET. No prices; not investment advice.